Marker Therapeutics MRKR
NASDAQ MRKR
$1.05 -0.02 (-1.87%)
At close: Oct 1, 2026 · 4:00 PM EDT

Marker Therapeutics (MRKR) Other financing activities (2010 - 2011)

Updated

Marker Therapeutics (MRKR) posted Other financing activities of $60,793 for Q4 2011, down 23.2% from the prior quarter.

Analysis

Marker Therapeutics (MRKR) Other financing activities (2010 - 2011) Analysis & Trends

For FY2011, Marker Therapeutics' Other financing activities came in at $140,000.

  • The Q4 2011 figure stands as the lowest quarterly Other financing activities since Q3 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Marker Therapeutics 17.87 Mn -42.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 60,793.00
Sep 30, 2011 79,207.00
Sep 30, 2010 16,131.00
API Access

Marker Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=MRKR&period=max&api_key=YOUR_API_KEY